|
Feb 14
|
3 Perfect Stocks to Buy This Valentine's Day
|
|
Feb 14
|
Amgen Takes Aim at Novo Nordisk and Eli Lilly, but Is the Stock a Buy?
|
|
Feb 13
|
Power Trader Challenges Texas Grid Policy Over Price Spikes
|
|
Feb 13
|
FDA warns online vendors selling misbranded weight-loss, diabetes drugs
|
|
Feb 13
|
Incyte's (INCY) Q4 Earnings & Revenues Fall Shy of Estimates
|
|
Feb 13
|
Eli Lilly partner BioAge raises $170 mln for obesity treatment
|
|
Feb 13
|
Move Aside, Eli Lilly and Novo Nordisk. Wall Street Thinks This Stock Will Be a Bigger Winner Over the Next 12 Months.
|
|
Feb 12
|
A Look at Pharma ETFs After Q4 Earnings
|
|
Feb 12
|
This Unstoppable Growth Stock Just Announced More Good News: Is It a Buy?
|
|
Feb 12
|
Could Eli Lilly's Zepbound Become the World's Best-Selling Drug?
|
|
Feb 10
|
CVS chief medical officer: 'We are not looking to build the entire healthcare delivery ecosystem'
|
|
Feb 10
|
Eli Lilly Just Succeeded Where Others Failed, but Does It Matter for the Stock?
|
|
Feb 10
|
30 Most Valuable Drug Companies in 2024
|
|
Feb 10
|
3 Stocks That Could Trounce the Market in 2024
|
|
Feb 10
|
PRIMECAP Management's Strategic Exits and New Positions Highlight Q4 Moves
|
|
Feb 10
|
15 Countries With Highest Pharmaceutical Spend Per Capita
|
|
Jan 16
|
These Stocks Are Showing Relative Strength as S&P 500 Stalls Near Record High
|
|
Jan 16
|
Analysts Predict The 10 Most-Valuable Stocks In 12 Months
|
|
Jan 16
|
UPDATE 2-Lilly exec eyes more weight-loss drug launches this year
|
|
Jan 16
|
Investors Heavily Search Eli Lilly and Company (LLY): Here is What You Need to Know
|